Insiders Ipsen

Equities

IPN

FR0010259150

Real-time Euronext Paris Other stock markets 04:55:48 2024-04-30 am EDT			5-day change	1st Jan Change
112.6 ^EUR	+0.09%		+1.08%	+4.36%

Apr. 24	IPSEN : Better-than-expected Q1; guidance unchanged
Apr. 24	Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ipsen: appointment of an independent director	23-09-04	CF
Ipsen appoints new R&D Director	23-09-01	CF
Ipsen appoints new Medical Director	23-04-24	CF
France's Ipsen Names Chief Medical Officer	23-04-24	MT
Ipsen Appoints Sandra Silvestri as EVP, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs, Effective 5 May 2023	23-04-24	CI
Cann Group Appoints CEO	23-01-09	MT
OSE Immunotherapeutics Appoints Ipsen Executive As CEO	22-07-14	MT
Ipsen Appoints Catherine Abi-Habib as EVP Strategy, Transformation, and Digital	22-02-16	CI
Ipsen Nominates Karen Witts as New Independent Board Member	22-01-21	CI
Ipsen Appoints Stewart Campbell as Executive Vice President and President of North America	21-11-03	CI
Ipsen Appoints Mari Scheiffele as EVP and President, Specialty Care International, Effective November 1, 2021	21-10-11	CI
Mirati Therapeutics : taps industry veteran Meek as CEO	21-09-20	RE
Ipsen Appoints Gwenan White as Executive Vice President Communications and Public Affairs	21-01-21	CI
Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer	20-09-25	CI
Ipsen Group Announces Executive Appointments	20-09-03	CI
Ipsen Announces Management Changes	20-05-29	CI
Ipsen Announces Board Changes	20-05-29	CI
Ipsen S.A. Appoints Steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, Effective March 1, 2020	20-01-14	CI
Ipsen : CEO resigns, to join Ferring unit	19-12-18	RE
Ipsen Announces Management Changes	19-12-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 10:50 am EDT